SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Farmer Brothers Co – ‘10-Q’ for 9/30/13 – ‘R16’

On:  Thursday, 11/7/13, at 5:14pm ET   ·   For:  9/30/13   ·   Accession #:  34563-13-52   ·   File #:  1-34249

Previous ‘10-Q’:  ‘10-Q’ on 5/6/13 for 3/31/13   ·   Next:  ‘10-Q’ on 2/10/14 for 12/31/13   ·   Latest:  ‘10-Q’ on 2/8/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

11/07/13  Farmer Brothers Co                10-Q        9/30/13   67:7.5M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    439K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     23K 
66: R1          Document and Entity Information                     HTML     41K 
44: R2          Consolidated Balance Sheets                         HTML    183K 
41: R3          Consolidated Balance Sheets (Parenthetical)         HTML     45K 
14: R4          Consolidated Statements of Operations               HTML     88K 
43: R5          Consolidated Statements of Comprehensive Income     HTML     43K 
29: R6          Consolidated Statements of Cash Flows               HTML    128K 
57: R7          Summary of Significant Accounting Policies          HTML     60K 
30: R8          Derivative Financial Instruments (Notes)            HTML    153K 
32: R9          Investments                                         HTML     49K 
15: R10         Fair Value Measurements (Notes)                     HTML     90K 
31: R11         Restricted Cash (Notes)                             HTML     27K 
56: R12         Accounts and Notes Receivable, net                  HTML     35K 
52: R13         Inventories                                         HTML     56K 
42: R14         Employee Benefit Plans                              HTML     79K 
63: R15         Bank Loan                                           HTML     41K 
55: R16         Share-Based Compensation                            HTML     87K 
12: R17         Income Taxes                                        HTML     53K 
17: R18         Earnings (Loss) Per Share                           HTML     44K 
62: R19         Summary of Significant Accounting Policies          HTML     88K 
                (Policies)                                                       
65: R20         Income Taxes Classification of Interest and         HTML     28K 
                Penalties (Policies)                                             
67: R21         Derivative Financial Instruments (Tables)           HTML    141K 
64: R22         Investments (Tables)                                HTML     43K 
47: R23         Fair Value Measurements (Tables)                    HTML     77K 
16: R24         Accounts and Notes Receivable, net (Tables)         HTML     32K 
28: R25         Inventories (Tables)                                HTML     50K 
21: R26         Employee Benefit Plans (Tables)                     HTML     62K 
20: R27         Share-Based Compensation (Tables)                   HTML     71K 
34: R28         Income Taxes (Tables)                               HTML     49K 
46: R29         Earnings (Loss) Per Share (Tables)                  HTML     41K 
53: R30         Summary of Significant Accounting Policies          HTML     44K 
                (Details)                                                        
26: R31         Derivative Financial Instruments - Narrative        HTML     50K 
                (Details)                                                        
35: R32         Derivative Financial Instruments - Fair Value of    HTML     34K 
                Derivative Instruments on the Consolidated Balance               
                Sheets (Details)                                                 
61: R33         Derivative Financial Instruments - Pretax Effect    HTML     33K 
                of Derivative Instruments on Earnings and OCI                    
                (Details)                                                        
23: R34         Derivative Financial Instruments - Net Realized     HTML     38K 
                and Unrealized Gains and Losses Recorded in                      
                "Other, net" (Details)                                           
50: R35         Derivative Financial Instruments - Schedule of      HTML     51K 
                Offsetting Derivative Assets and Liabilities                     
                (Details)                                                        
51: R36         Investments - Narrative (Details)                   HTML     26K 
36: R37         Investments - Gross Unrealized Losses (Details)     HTML     28K 
19: R38         Fair Value Measurements - Assets and Liabilities    HTML     59K 
                Measured and Recorded at Fair Value on a Recurring               
                Basis (Details)                                                  
49: R39         Restricted Cash (Details)                           HTML     23K 
24: R40         Accounts and Notes Receivable, net - Schedule of    HTML     30K 
                Accounts Receivable (Details)                                    
33: R41         Inventories - Narrative (Details)                   HTML     23K 
54: R42         Inventories - Schedule of Inventory (Details)       HTML     34K 
27: R43         Employee Benefit Plans - Narrative (Details)        HTML     52K 
48: R44         Employee Benefit Plans - Components of Net          HTML     64K 
                Periodic Benefit Cost and Amounts Recognized in                  
                Other Comprehensive Income (Details)                             
40: R45         Bank Loan (Details)                                 HTML     77K 
22: R46         Share-Based Compensation - Narrative (Details)      HTML     57K 
60: R47         Share-Based Compensation - Stock Option Activity    HTML    103K 
                (Details)                                                        
18: R48         Share-Based Compensation - Restricted Stock         HTML     74K 
                Activity (Details)                                               
25: R49         Income Taxes - Narrative (Details)                  HTML     26K 
39: R50         Income Taxes - Summary of Income Tax Expense        HTML     40K 
                Recorded (Details)                                               
45: R51         Income Taxes - Unrecognized Tax Benefits (Details)  HTML     27K 
58: R52         Earnings (Loss) Per Share (Details)                 HTML     57K 
38: XML         IDEA XML File -- Filing Summary                      XML     98K 
13: EXCEL       IDEA Workbook of Financial Reports                  XLSX    159K 
37: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   1.13M 
 6: EX-101.INS  XBRL Instance -- farm-20130930                       XML   1.58M 
 8: EX-101.CAL  XBRL Calculations -- farm-20130930_cal               XML    191K 
 9: EX-101.DEF  XBRL Definitions -- farm-20130930_def                XML    383K 
10: EX-101.LAB  XBRL Labels -- farm-20130930_lab                     XML   1.33M 
11: EX-101.PRE  XBRL Presentations -- farm-20130930_pre              XML    693K 
 7: EX-101.SCH  XBRL Schema -- farm-20130930                         XSD    139K 
59: ZIP         XBRL Zipped Folder -- 0000034563-13-000052-xbrl      Zip    181K 


‘R16’   —   Share-Based Compensation


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v2.4.0.8
Share-Based Compensation
3 Months Ended
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation
Share-based Compensation
On August 23, 2007, the Company’s Board of Directors approved the Farmer Bros. Co. 2007 Omnibus Plan (the “Omnibus Plan”), which was approved by stockholders on December 6, 2007. On December 6, 2012, the stockholders approved an amendment to increase the maximum number of shares of common stock available for issuance under the Omnibus Plan to 1,125,000 from 1,000,000, subject to adjustment as provided in the Omnibus Plan. Prior to adoption of the Omnibus Plan the Company had no share-based compensation plan. Awards issued under the Omnibus Plan may take the form of stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalents, performance-based awards, stock payments, cash-based awards or other incentives payable in cash or shares of stock, or any combination thereof. Each award will be set forth in a separate agreement with the person receiving the award and will indicate the type, terms and conditions of the award. The Company has placed a proposal on the ballot for its upcoming Annual Meeting of Stockholders requesting stockholder approval of the Farmer Bros. Co. Amended and Restated 2007 Long-Term Incentive Plan (the "Amended Equity Plan"), which is an amendment and restatement of, and successor to, the Omnibus Plan. If approved by stockholders, the Amended Equity Plan would implement certain material changes to the Omnibus Plan, including, without limitation, an increase in the number of shares of common stock authorized for issuance of awards by 250,000 from 1,125,000 to 1,375,000.
The Company measures and recognizes compensation expense for all share-based payment awards made under the Omnibus Plan based on estimated fair values. No stock options were granted during the three months ended September 30, 2013 or 2012.
Stock Options
The Company estimates the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service period in the Company’s consolidated statements of operations.
Share-based compensation expense recognized during the period is based on the value of the portion of share-based payment awards that is ultimately expected to vest during the period. Compensation expense recognized for all stock option awards granted is recognized using the straight-line method over the vesting period. The options generally vest ratably over a period of 3 years, however, fiscal 2012 grants included nonqualified stock option awards to executive officers with different vesting periods, in each case, subject to certain events of acceleration as provided in the applicable employment agreement or award agreement with the executive officer.
The share-based compensation expense recognized in the Company’s consolidated statements of operations for the three months ended September 30, 2013 and 2012 is based on awards ultimately expected to vest. Currently, management estimates an annual forfeiture rate of 6.5% based on actual forfeiture experience from the inception of the Omnibus Plan. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
The Company uses the Black-Scholes option valuation model, which requires management to make certain assumptions for estimating the fair value of stock options at the date of the grant. The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. In addition, option valuation models require the input of highly subjective assumptions including the expected stock price volatility. Because the Company’s stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimates, in management’s opinion the existing models may not necessarily provide a reliable single measure of the fair value of the Company’s stock options. Although the fair value of stock options is determined using an option valuation model that value may not be indicative of the fair value observed in a willing buyer/willing seller market transaction.
The Company’s assumption regarding expected stock price volatility is based on the historical volatility of the Company’s stock price. The risk-free interest rate is based on U.S. Treasury zero-coupon issues at the date of grant with a remaining term equal to the expected life of the stock options. The average expected life is based on the midpoint between the vesting date and the end of the contractual term of the award.
 
The following table summarizes stock option activity for the three months ended September 30, 2013 (unaudited):
Outstanding Stock Options:
 
Number
of
Stock
Options
 
Weighted
Average
Exercise
Price ($)
 
Weighted
Average
Grant Date
Fair Value ($)
 
Weighted
Average
Remaining
Life
(Years)
 
Aggregate
Intrinsic
Value
(Dollars in thousands)
Outstanding at June 30, 2013
 
557,427

 
12.81
 
5.44
 
5.1
 
1,620

Granted
 

 
 
 
 

Exercised
 
(346
)
 
7.42
 
3.64
 
 
3

Cancelled/Forfeited
 
(11,681
)
 
19.00
 
6.65
 
 

Outstanding at September 30, 2013
 
545,400

 
12.68
 
5.41
 
5.0
 
1,996

Vested and exercisable, September 30, 2013
 
231,663

 
15.22
 
5.81
 
3.8
 
604

Vested and expected to vest, September 30, 2013
 
522,652

 
12.76
 
5.42
 
3.8
 
1,899


 
The aggregate intrinsic values in the table above represent the total pretax intrinsic value, based on the Company’s closing stock price of $15.06 at September 30, 2013, representing the last trading day of the fiscal quarter ended September 30, 2013, which would have been received by award holders had all award holders exercised their awards that were in-the-money as of that date. Total fair value of options vested during the three months ended September 30, 2013 was $0.
As of September 30, 2013 and 2012, there was approximately $1.2 million and $1.1 million, respectively, of unrecognized compensation cost related to stock options. Compensation expense recognized in general and administrative expenses in each of the three months ended September 30, 2013 and 2012 was $0.2 million.
Restricted Stock
No shares of of restricted stock were awarded during the three months ended September 30, 2013. During the three months ended September 30, 2012, the Company granted a total of 6,830 shares of restricted stock with a weighted average grant date fair value of $9.06. Shares of restricted stock generally vest at the end of three years for eligible employees and officers who are employees. The fiscal 2012 grants included awards to executive officers with different vesting periods, in each case, subject to accelerated vesting as provided in the applicable employment agreement or award agreement with the executive officer. Shares of restricted stock generally vest ratably over a period of three years for directors.
Compensation expense is recognized on a straight-line basis over the service period based on the estimated fair value of the restricted stock. Compensation expense recognized in general and administrative expenses for the three months ended September 30, 2013 and 2012 was $0.1 million and $0.2 million, respectively. As of September 30, 2013 and 2012, there was approximately $0.8 million and $1.1 million, respectively, of unrecognized compensation cost related to restricted stock.
The following table summarizes restricted stock activity for the three months ended September 30, 2013 (unaudited):
Outstanding and Nonvested Restricted Stock Awards:
 
Shares
Awarded
 
Weighted
Average
Grant Date
Fair Value
($)
 
Weighted
Average
Remaining
Life
(Years)
 
Aggregate
Intrinsic
Value
($ in thousands)
Outstanding at June 30, 2013
 
139,360

 
9.87

 
1.9
 
1,959

Granted
 

 

 
 

Exercised/Released
 

 

 
 

Cancelled/Forfeited
 
(556
)
 
8.84

 
 

Outstanding at September 30, 2013
 
138,804

 
9.87

 
1.7
 
2,090

Expected to vest, September 30, 2013
 
116,645

 
9.85

 
1.7
 
1,757


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:11/7/138-K
For Period end:9/30/138-K
6/30/1310-K
12/6/123,  8-K
9/30/1210-Q
9/15/0910-K/A,  8-K
12/6/073,  8-K,  DEF 14A
8/23/073,  8-K,  8-K/A
 List all Filings 
Top
Filing Submission 0000034563-13-000052   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 5:21:51.1pm ET